Varying dolutegravir distribution across the body may affect the drug’s ability to suppress the HIV reservoir
People need pathways from PEP to PrEP – and back again
Sexually transmitted infections in San Francisco have fallen since doxyPEP roll-out
Full analysis of French STI study dashes hopes for a gonorrhoea vaccine
Injectable treatment just as effective as standard HIV combination in Africa
